3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
108
Stomach Neoplasms
68
Pancreatic Neoplasms
33
Neoplasms
24
Lymphoma, Large B-Cell, Diffuse
22
Carcinoma, Non-Small-Cell Lung
21
Neoplasm Metastasis
18
Rectal Neoplasms
17
Colonic Neoplasms
17
Esophageal Neoplasms
16
Parkinson Disease 4, Autosomal Dominant Lewy Body
13
Adenocarcinoma
13
Carcinoma, Hepatocellular
12
Ovarian Neoplasms
10
Biliary Tract Neoplasms
9
Adenocarcinoma Of Esophagus
9
Esophageal Squamous Cell Carcinoma
8
Cholangiocarcinoma
8
Gastrointestinal Neoplasms
7
Lymphoma, Non-Hodgkin
6
Endometrial Neoplasms
6
Gallbladder Neoplasms
5
Advanced Solid Tumors
5
Triple Negative Breast Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Recurrence
4
Carcinoma, Pancreatic Ductal
4
Breast Neoplasms
4
Advanced Solid Tumor
4
Solid Tumors
3
Interventions
Gemcitabine
2
Oxaliplatin
1
Leucovorin
1
Irinotecan
1
Fluorouracil
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Locally Advanced Pancreatic Cancer
×
Oxaliplatin
×
Clear all
NCT05466799
2026-02-13
TRIPP-FFX
OncoSil Medical Limited
Phase 2
Active not recruiting
88 enrolled